B-cell maturation antigen is modified by a single N-glycan chain that modulates ligand binding and surface retention

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 27, 2013, Pages 10928-10933

  Huang, Han Wen ^a,b   Chen, Chein Hung ^b   Lin, Chun Hung ^b,c   Wong, Chi Huey ^a,b   Lin, Kuo I ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYNYL GROUP; APRIL PROTEIN; B CELL ACTIVATING FACTOR; B CELL MATURATION ANTIGEN; DEXAMETHASONE; GLYCAN; GLYCOPROTEIN; SIALIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURFACE; CLICK CHEMISTRY; FUCOSYLATION; GLYCOSYLATION; HUMAN; HUMAN CELL; LIGAND BINDING; MASS SPECTROMETRY; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SIALYLATION;

ASPARAGINE; B-CELL MATURATION ANTIGEN; BINDING SITES; CELL LINE, TUMOR; CELL MEMBRANE; CLICK CHEMISTRY; GLYCOSYLATION; HUMANS; LIGANDS; MULTIPLE MYELOMA; PLASMA CELLS; POLYSACCHARIDES;

EID: 84879698767     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1309417110     Document Type: Article

References (46)

1. Darce JR, Arendt BK, Wu X, Jelinek DF (2007) Regulated expression of BAFF-binding receptors during human B cell differentiation. J Immunol 179(11):7276-7286.
2. Yang M, et al. (2005) B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J Immunol 175(5):2814-2824. (Pubitemid 41170498)
3. O'Connor BP, et al. (2004) BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 199(1):91-98.
4. Mackay F, Ambrose C (2003) The TNF family members BAFF and APRIL: The growing complexity. Cytokine Growth Factor Rev 14(3-4):311-324. (Pubitemid 36693150)
5. Schneider P (2005) The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 17(3):282-289.
6. Bossen C, Schneider P (2006) BAFF, APRIL and their receptors: Structure, function and signaling. Semin Immunol 18(5):263-275. (Pubitemid 44287558)
7. Hatzoglou A, et al. (2000) TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J Immunol 165(3):1322-1330. (Pubitemid 30604561)
8. Alexaki VI, et al. (2009) Adipocytes as immune cells: Differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development. J Immunol 183(9):5948-5956.
9. Zonca M, et al. (2012) APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase. Tissue Eng Part A 18(7 - 8):852-859.
10. Deshayes F, et al. (2004) Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor. Oncogene 23(17):3005-3012. (Pubitemid 38648191)
11. Novak AJ, et al. (2004) Expression of BCMA, TACI, and BAFF-R in multiple myeloma: A mechanism for growth and survival. Blood 103(2):689-694. (Pubitemid 38140105)
12. Novak AJ, Bram RJ, Kay NE, Jelinek DF (2002) Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: A mechanism for survival. Blood 100(8):2973-2979.
13. Kern C, et al. (2004) Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 103(2):679-688. (Pubitemid 38145555)
14. Chiu A, et al. (2007) Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood 109(2):729-739. (Pubitemid 46105975)
15. Endo T, et al. (2007) BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway. Blood 109(2):703-710. (Pubitemid 46105972)
16. Nagatani K, et al. (2007) Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL. Arthritis Rheum 56(11):3554-3563. (Pubitemid 350100688)
17. Kim J, Gross JA, Dillon SR, Min JK, Elkon KB (2011) Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation. Autoimmunity 44(2):69-81.
18. Koarada S, et al. (2010) Autoantibody-producing RP105(-) B cells, from patients with systemic lupus erythematosus, showed more preferential expression of BCMA compared with BAFF-R than normal subjects. Rheumatology (Oxford) 49(4):662-670.
19. Rennert P, et al. (2000) A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J Exp Med 192(11):1677-1684.
20. Tai YT, et al. (2006) Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. Cancer Res 66(13):6675-6682.
21. Ryan MC, et al. (2007) Antibody targeting of B-cell maturation antigen on malignant plasma cells. Mol Cancer Ther 6(11):3009-3018. (Pubitemid 350206779)
22. Gross JA, et al. (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404(6781):995-999. (Pubitemid 30243593)
23. Dillon SR, Gross JA, Ansell SM, Novak AJ (2006) An APRIL to remember: Novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5(3):235-246. (Pubitemid 43336036)
24. Varki A (1993) Biological roles of oligosaccharides: All of the theories are correct. Glycobiology 3(2):97-130.
25. Partridge EA, et al. (2004) Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306(5693):120-124. (Pubitemid 39451953)
26. Hanson SR, et al. (2007) Tailored glycoproteomics and glycan site mapping using saccharide-selective bioorthogonal probes. J Am Chem Soc 129(23):7266-7267. (Pubitemid 46980800)
27. Gras MP, et al. (1995) BCMAp: An integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int Immunol 7(7):1093-1106.
28. Tsai CM, et al. (2011) Galectin-1 and galectin-8 have redundant roles in promoting plasma cell formation. J Immunol 187(4):1643-1652.
29. Moreaux J, et al. (2004) BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 103(8):3148-3157. (Pubitemid 38451693)
30. Hymowitz SG, et al. (2005) Structures of APRIL-receptor complexes: Like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J Biol Chem 280(8):7218-7227. (Pubitemid 40341279)
31. Liu YC, et al. (2011) Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc Natl Acad Sci USA 108(28):11332-11337.
32. Park JJ, et al. (2012) Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells. Biochem Pharmacol 83(7):849-857.
33. Swindall AF, Bellis SL (2011) Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. J Biol Chem 286(26):22982-22990.
34. Toscano MA, et al. (2007) Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol 8(8):825-834. (Pubitemid 47099035)
35. Zhuo Y, Chammas R, Bellis SL (2008) Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem 283(32):22177-22185.
36. Liu W, et al. (2012) Galectin-3 regulates intracellular trafficking of EGFR through Alix and promotes keratinocyte migration. J Invest Dermatol 132(12):2828-2837.
37. Cha SK, et al. (2008) Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci USA 105(28):9805-9810.
38. Hirabayashi J, et al. (2002) Oligosaccharide specificity of galectins: A search by frontal affinity chromatography. Biochim Biophys Acta 1572(2-3):232-254. (Pubitemid 35246347)
39. Lau KS, et al. (2007) Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129(1):123-134. (Pubitemid 46507588)
40. Crocker PR, Paulson JC, Varki A (2007) Siglecs and their roles in the immune system. Nat Rev Immunol 7(4):255-266. (Pubitemid 46480955)
41. Chen WC, et al. (2012) Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169. PLoS ONE 7(6):e39039.
42. O'Reilly MK, Tian H, Paulson JC (2011) CD22 is a recycling receptor that can shuttle cargo between the cell surface and endosomal compartments of B cells. J Immunol 186(3):1554-1563.
43. Scott CJ, et al. (2008) Immunocolloidal targeting of the endocytotic siglec-7 receptor using peripheral attachment of siglec-7 antibodies to poly(lactide-co-glycolide) nanoparticles. Pharm Res 25(1):135-146.
44. Doody GM, et al. (1995) A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269(5221):242-244.
45. Hanson SR, et al. (2009) The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability. Proc Natl Acad Sci USA 106(9):3131-3136.
46. Hsu TL, et al. (2007) Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells. Proc Natl Acad Sci USA 104(8):2614-2619.